- Open Access
Geographical origin of Plasmodium vivax in the Republic of Korea: haplotype network analysis based on the parasite's mitochondrial genome
- Moritoshi Iwagami†1,
- Seung-Young Hwang†2,
- Megumi Fukumoto1, 3,
- Toshiyuki Hayakawa4,
- Kazuyuki Tanabe4,
- So-Hee Kim5,
- Weon-Gyu Kho2, 5Email author and
- Shigeyuki Kano1, 3Email author
© Iwagami et al; licensee BioMed Central Ltd. 2010
- Received: 30 March 2010
- Accepted: 25 June 2010
- Published: 25 June 2010
The Republic of Korea (South Korea) is one of the countries where vivax malaria had been successfully eradicated by the late 1970s. However, re-emergence of vivax malaria in South Korea was reported in 1993. Several epidemiological studies and some genetic studies using antigenic molecules of Plasmodium vivax in the country have been reported, but the evolutionary history of P. vivax has not been fully understood. In this study, the origin of the South Korean P. vivax population was estimated by molecular phylogeographic analysis.
A haplotype network analysis based on P. vivax mitochondrial (mt) DNA sequences was conducted on 11 P. vivax isolates from South Korea and another 282 P. vivax isolates collected worldwide.
The network analysis of P. vivax mtDNA sequences showed that the coexistence of two different groups (A and B) in South Korea. Groups A and B were identical or close to two different populations in southern China.
Although the direct introduction of the two P. vivax populations in South Korea were thought to have been from North Korea, the results of this analysis suggest the genealogical origin to be the two different populations in southern China.
- Korean Peninsula
- Vivax Malaria
- Haplotype Network
- Antigenic Molecule
Malaria is distributed not only in tropical and subtropical areas but also in some temperate areas of the world. Plasmodium falciparum, which is distributed in tropical and subtropical areas, accounts for 90% of malaria cases. Like P. falciparum, Plasmodium vivax is distributed in tropical and subtropical areas, but its range extends to some temperate areas. In Asian and South American countries, the proportion of P. falciparum cases is gradually decreasing due to global malaria controls programmes, such as The Roll Back Malaria Partnership and The Global Fund. On the other hand, the proportion of P. vivax cases is gradually increasing . Therefore, P. vivax should be given greater attention than it has received.
The Republic of Korea (South Korea) is one of the countries where vivax malaria had been successfully eradicated by the late 1970s. This was due to an effective national eradication programme conducted by the National Malaria Eradication Service under the operation of the South Korean government with the support of the WHO [2–4]. However, in 1993, the first case of indigenous vivax malaria after the eradication program was reported from the border area between North and South Korea in the western Demilitarized Zone (DMZ) . The number of cases steadily increased until 2000 (4,142 cases), at which point they began to gradually decrease until 2004 (864 cases). However, in 2005, 2006 and 2007, the number of reported cases increased again (1,311, 2,019 and 2,203 cases, respectively) . Initially, the patients were South Korean soldiers or veterans that had served in the western DMZ. However, the numbers of vivax cases among civilians living in the area were also gradually increasing . According to the WHO, vivax malaria in the Democratic People's Republic of Korea (North Korea), with 99,582 reported cases in 1999; 298,058 cases in 2001; and 34,485 cases in 2004, was more prevalent than in South Korea [7, 8].
Plasmodium vivax in South and North Korea has unique characteristics, such as a long incubation period (maximum 13 months), seasonal transmission (only the summer season) and it is adapted to a cold climate [3, 9–15]: the endemic areas are covered with snow in winter season. Although the evolutionary history of P. vivax from other countries has recently been addressed, thus far the history of P. vivax in the Korean peninsula (South and North Korea) has not been clearly understood [16–18]. Several epidemiological data showed that the re-emergence of vivax malaria in South Korea would be the introduction from North Korea through the DMZ [3–8]. However, the geographical origin of P. vivax population in the Korean peninsula has not been determined so far. In the present study, in order to estimate geographical origin of the P. vivax population in the Korean peninsula, phylogeographic analysis of the P. vivax population in South Korea and the other populations worldwide (including a North Korean isolate) was conducted.
Ten blood samples were collected from vivax malaria patients who were South Korean soldiers that served in the DMZ in 1999. One blood sample was collected from a Korean visitor to Japan in 2002. He was a veteran in the Korean army who had served in the DMZ before he visited Japan and had never been abroad before his visit [19, 20]. The patient blood samples were preserved at -30°C until use. These patients were also diagnosed by microscopic examination of peripheral blood smears. This study was performed according to the ethical guidelines for epidemiological studies provided by the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare of Japan.
DNA extraction, Polymerase chain reaction (PCR) and DNA sequencing
The parasite DNA was extracted from the frozen whole blood samples by phenol-chloroform extraction after proteinase K digestion . The whole mitochondrial (mt) DNA sequences (approx. 6 Kb) of the P. vivax isolates form South Korea were amplified by PCR using three pairs of primer sets:
Pv-mt1 F (5'-TTCCACTACCAAAATATAATCTCCT-3')
Pv-mt1 R (5'-CACACAAAATCACCGTTCTTATAAA-3')
Pv-mt2 F (5'-TAAATGTGCTTTAATATTATTATAG-3')
Pv-mt2 R (5'-CATAATTCCATAAGAAATTAATATT-3')
Pv-mt3 F (5'-ATCAACAATGACTTTATTTGGTTTA-3')
Pv-mt3 R (5'-ACTATAAAACATGTGATCTAATTAC-3'), which were designed form the mt sequence of the P. vivax af20012 isolate [GenBank: AY791517]. Three amplified DNA fragments (approx. 2 Kb) overlapped with each other. Sequencing of the PCR products was performed using an Applied Biosystems 310 Genetic Analyzer (Applied Biosystems Inc, Foster City, CA, USA), using ABI PRISM Big Dye Terminator v.3.1 (Applied Biosystems Inc, Foster City, CA, USA).
MtDNA sequences (approx. 6 Kb) of the 11 P. vivax isolates from South Korea (present study) [DDBJ: AB550270-AB550280] and another 282 P. vivax isolates collected worldwide that had been deposited in the GenBank database, were used for phylogenetic analysis [16, 17]. Mu et al  deposited 176 sequences [GenBank: AY791517.1-AY791692.1]. Jongwutiwes et al  deposited 106 sequences [GenBank: AY598035.1-AY598140.1]. DNA alignment of the whole mtDNA sequences of the P. vivax isolates was performed by the DNA Alignment version 22.214.171.124 computer software (Fluxus Technology Ltd.) . A haplotype network was constructed based on polymorphic sites of the whole mtDNA sequences of the isolates using the Median-Joining method in the NETWORK version 126.96.36.199 computer software (Fluxus Technology Ltd.) .
In a previous report, Kho et al  also noted the observation of two types of genotypes (i.e. SK type A and B) in some antigenic molecules of P. vivax in South Korean populations. In the present study, 91% of the isolates (10/11) were correlated to the results of the previous studies on the antigenic molecules: the South Korean isolates in the group A complex had SK type A antigenic molecules, and the South Korean isolates in the group B complex had SK type B antigenic molecules (Additional File 2).
The group A complex was genetically close to Southeast Asian populations (shown in gray); most of them were isolates from Thailand and Vietnam, or close to the South Asian population (shown in black); they were isolates from India, Pakistan and Iran (Figure 1). The group B complex was genetically close to the Indonesia population (shown in blue). Generally, old (or ancestral) populations are more genetically diverged than young populations. In this context, the Southeast Asian populations (shown in gray) and Papua New Guinean populations (shown in white) seemed old populations. Considering a possible population expansion, the group B complex seemed to have diverged from the Indonesian population (Figure 1). The genetic divergence of the extant P. vivax populations in the world is presumably a result of ancient hominid geographic expansion . Therefore, the relationships between the group B complex and the Indonesian population suggests a possibility that the expansion of P. vivax population(s) from Indonesia to southern China was brought about with the migration(s) of ancient hominids. Another possible scenario is that the group B complex has directly diverged from the Southeast Asian populations because some isolates from Southeast Asia are identical to those from Indonesia. In this scenario, the expansion of P. vivax population(s) from Southeast Asia to Indonesia was also brought about with the migration(s) of ancient hominids. Although the present South Korean P. vivax populations are believed to have recently derived from North Korea via the DMZ, this study suggests that the P. vivax lineages in the Korean peninsula have their genealogical ancestor in P. vivax populations from southern China.
One of the remarkable characteristics of P. vivax in Korean peninsula is its evolutionary adaptation to the cold climate. The long incubation period of Korean P. vivax is the key to the adaptation, because the parasites in the liver cells of the human host appears in the blood streams from the liver cells mainly between June and September (around the summer season) when mosquitoes are highly prevalent, but the parasites remain in the liver cells in the other colder seasons when mosquitoes are not present [3, 9, 15]. In this phenomenon, it seems as if the parasites are waiting for the mosquitoes within the host liver cells by regulating the duration of the incubation period.
Several workers reported that there seem to be two types of P. vivax strains (or populations) in the Korean peninsula: one with a short incubation period and the other with a long incubation period. The incubation period of the former type of North Korean strain is 14 days to 1 month, and the incubation period of the latter type of strain is 8 months to 13 months, as determined by experimental infection to humans through bites of the infected mosquitoes . The proportion of strains (or populations) showing the short incubation period was 26.0%, whereas the proportion of strains (or populations) showing the long incubation period was 74.0% . One mtDNA sequence of a North Korean isolate deposited in the GenBank database was included in the present study. The North Korean isolate was shown as No. 2 (shown in dark green) in the group B complex in the haplotype network in Figure 1. The information of the incubation period of the North Korean isolate was not obtained.
One isolate from the imported patient in Japan [19, 20] with a long incubation period (at least eight months) was also grouped in the group B complex shown as No. 1 in the haplotype network (Figure 1). The information on the duration of the incubation period of the other 10 South Korean isolates used in this study has not been obtained thus far, but the branching patterns in the network tree appear to be related to the phenotypic characteristics of the parasites within the host.
Further study is needed to demonstrate whether the two groups of South Korean isolates (groups A and B) correlate with some clinical or epidemiological differences in the endemic areas. Haplotype network analysis using the mtDNA sequences of P. vivax is a useful tool for estimating the geographical origin of isolates as well as for the prediction of probable phenotypes.
The direct introduction of the present P. vivax populations to South Korea is thought to be from North Korea via the DMZ, but the true origin of the P. vivax populations in the Korean peninsula is now suggested to be from the two different P. vivax populations in southern China.
The authors wish to thank Dr. Pannapa Susomboon, Research Institute, International Medical Center of Japan, for her technical assistance in this study. This work was supported by a Grant-in-Aid for Scientific Research (B) (19406013) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
- World Health Organization (WHO): World Malaria Report. 2008, Geneva: WHOGoogle Scholar
- Chai JY: Re-emerging Plasmodium vivax malaria in the Republic of Korea. Korean J Parasitol. 1999, 37: 129-143. 10.3347/kjp.19188.8.131.52.PubMed CentralView ArticlePubMedGoogle Scholar
- Ree HI: Unstable vivax malaria in Korea. Korean J Parasitol. 2000, 38: 119-138. 10.3347/kjp.2000.38.3.119.PubMed CentralView ArticlePubMedGoogle Scholar
- Shin EH, Guk SM, Kim HJ, Lee SH, Chai JY: Trends in parasitic diseases in the Republic of Korea. Trends Parasitol. 2008, 24: 143-150. 10.1016/j.pt.2007.12.003.View ArticlePubMedGoogle Scholar
- Chai IH, Lim GI, Yoon SN, Oh WI, Kim SJ, Chai JY: Occurrence of tertian malaria in a male patient who has never been abroad. Korean J Parasitol. 1994, 32: 195-200. 10.3347/kjp.19184.108.40.206. (in Korean, English abstract available)View ArticlePubMedGoogle Scholar
- Park JW, Jun G, Yeom JS: Plasmodium vivax malaria: status in the Republic of Korea following reemergence. Korean J Parasitol. 2009, 47 (Suppl): S39-50. 10.3347/kjp.2009.47.S.S39.PubMed CentralView ArticlePubMedGoogle Scholar
- Han ET, Lee DH, Park KD, Seok WS, Kim YS, Tsuboi T, Shin EH, Chai JY: Reemerging vivax malaria: changing patterns of annual incidence and control programs in the Republic of Korea. Korean J Parasitol. 2006, 44: 285-294. 10.3347/kjp.2006.44.4.285.PubMed CentralView ArticlePubMedGoogle Scholar
- Choi YK, Choi KM, Park MH, Lee EG, Kim YJ, Lee BC, Cho SH, Rhie HG, Lee HS, Yu JR, Lee JS, Kim TS, Kim JY: Rapid dissemination of newly introduced Plasmodium vivax genotypes in South Korea. Am J Trop Med Hyg. 2010, 82: 426-432. 10.4269/ajtmh.2010.09-0245.PubMed CentralView ArticlePubMedGoogle Scholar
- Hasegawa Y: Malaria in Korea. J Chosun Med Soc. 1913, 4: 53-69. (in Japanese. No English abstract available)Google Scholar
- Eddleman EE, Hale WH, Snowden WM: Vivax malaria with long incubation period, Report of seven cases. US Armed Forces Med J. 1951, 2: 1693-1698.Google Scholar
- Hall WH, Loomis GW: Vivax malaria in veterans of the Korean war. A preliminary report of 25 cases. New Engl J Med. 1952, 246: 90-93.View ArticlePubMedGoogle Scholar
- Brunetti R: Outbreak malaria with prolonged incubation period in California, a nonendemic area. Science. 1954, 119: 74-75. 10.1126/science.119.3080.74.View ArticlePubMedGoogle Scholar
- Brunetti R, Fritz RF, Hollister AC: An outbreak of malaria in California, 1952-1953. Am J Trop Med Hyg. 1954, 3: 779-788.PubMedGoogle Scholar
- Tiburskaja NA, Sergiev PG, Vrublevskaja OS: Dates of onset of relapses and the duration of infection in induced tertian malaria with short and long incubation periods. Bull World Health Organ. 1968, 38: 447-457.PubMed CentralPubMedGoogle Scholar
- NMES: Malaria pre-eradication programme in Korea. Progress report, 1961-1965 Ministry of Health and Social Affairs of Korea. 1966, 75-(in Korean)Google Scholar
- Mu J, Joy DA, Duan J, Huang Y, Carlton J, Walker J, Barnwell J, Beerli P, Charleston MA, Pybus OG, Su XZ: Host switch leads to emergence of Plasmodium vivax malaria in humans. Mol Biol Evol. 2005, 22: 1686-1693. 10.1093/molbev/msi160.View ArticlePubMedGoogle Scholar
- Jongwutiwes S, Putaporntip C, Iwasaki T, Ferreira MU, Kanbara H, Hughes AL: Mitochondrial genome sequences support ancient population expansion in Plasmodium vivax. Mol Biol Evol. 2005, 22: 1733-1739. 10.1093/molbev/msi168.PubMed CentralView ArticlePubMedGoogle Scholar
- Cornejo OE, Escalante AA: The origin and age of Plasmodium vivax. Trends Parasitol. 2006, 22: 558-63. 10.1016/j.pt.2006.09.007.PubMed CentralView ArticlePubMedGoogle Scholar
- Itoda I, Kaneko Y, Yasunami T, Kikuchi K, Yamaura H, Totsuka K: A case of imported Plasmodium vivax malaria from the demilitarized zone in South Korea. Kansenshogaku Zasshi. 2003, 77: 42-44. (in Japanese. No English abstract available)View ArticlePubMedGoogle Scholar
- Iwagami M, Itoda I, Hwang SY, Kho WG, Kano S: Plasmodium vivax PCR genotyping of the first malaria case imported from South Korea into Japan. J Infect Chemother. 2009, 15: 27-33. 10.1007/s10156-008-0658-4.View ArticlePubMedGoogle Scholar
- Sambrook J, Russell DW: Molecular Cloning: A Laboratory Manual. 2001, New York: Cold Harbor Laboratory Press, 3Google Scholar
- DNA Alignment version 220.127.116.11. 2008, Fluxus Technology Ltd, [http://www.fluxus-engineering.com/align.htm]
- Network version 18.104.22.168. 2009, Fluxus Technology Ltd, [http://www.fluxus-engineering.com/netwinfo.htm]
- Hwang SY, Kim SH, Kho WG: Genetic characteristics of polymorphic antigenic markers among Korean isolates of Plasmodium vivax. Korean J Parasitol. 2009, 47 (Suppl): S51-58. 10.3347/kjp.2009.47.S.S51.PubMed CentralView ArticlePubMedGoogle Scholar
- Tiburskaja NA, Vrublevskaja OS: The course of infection caused by the North Korean strain of Plasmodium vivax. WHO/MAL/77. 1977, 895: 1-19.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.